Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

KEFLIN ADD-VANTAGE INJ 1GM/VIAL DIN 00752525

Status: Cancelled Post Market
Holder: ELI LILLY CANADA INC
Molecule: CEPHALOTHIN (CEPHALOTHIN SODIUM)

Health Canada record

Active ingredient(s)CEPHALOTHIN (CEPHALOTHIN SODIUM) 1 G
Dosage formLiquid
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ01DB03 CEFALOTIN
Original market date31-Dec-1988
Current status date04-Aug-1998
SourceHealth Canada DPD

Establishment licence of the holder

Eli Lilly Canada Inc. — licence 100164, currently licensed, last inspection rating C (2026-03-24).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CEPHALOTHIN (CEPHALOTHIN SODIUM)

DINProductCompanyFormStrengthStatus
02060051CEPORACINMYLAN PHARMACEUTICALS ULCPowder For SolutionCEPHALOTHIN (CEPHALOTHIN SODIUM) 1 GCancelled Post Market
00015369KEFLIN NEUTRAL INJ 1GMELI LILLY CANADA INCPowder For SolutionCEPHALOTHIN (CEPHALOTHIN SODIUM) 1 GCancelled Post Market
Request a quote for KEFLIN ADD-VANTAGE INJ 1GM/VIAL

How to read a Canadian DIN record